Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1.
about
Evidence for a genomic mechanism of action for progesterone receptor membrane component-1Progesterone inhibits apoptosis in part by PGRMC1-regulated gene expression.The σ2 receptor: a novel protein for the imaging and treatment of cancer.Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression.Down-regulation of progesterone receptor membrane component 1 (PGRMC1) in peripheral nucleated blood cells associated with premature ovarian failure (POF) and polycystic ovary syndrome (PCOS).Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity.Role of protein-protein interactions in cytochrome P450-mediated drug metabolism and toxicityS2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling.The effect of progesterone replacement on gene expression in the corpus luteum during induced regression and late luteal phase in the bonnet monkey (Macaca radiata).Antiprogestins in gynecological diseases.Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumorsProgesterone signaling mediated through progesterone receptor membrane component-1 in ovarian cells with special emphasis on ovarian cancerOverexpression of fatty acid synthase in Middle Eastern epithelial ovarian carcinoma activates AKT and Its inhibition potentiates cisplatin-induced apoptosis.Plasminogen activator inhibitor 1 RNA-binding protein interacts with progesterone receptor membrane component 1 to regulate progesterone's ability to maintain the viability of spontaneously immortalized granulosa cells and rat granulosa cellsNeutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1.PGRMC1 Is a Novel Potential Tumor Biomarker of Human Renal Cell Carcinoma Based on Quantitative Proteomic and Integrative Biological AssessmentsProgesterone receptor membrane component-1 regulates hepcidin biosynthesisHaem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistanceProgesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors.Hormone response in ovarian cancer: time to reconsider as a clinical target?PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.PGRMC1 participates in late events of bovine granulosa cells mitosis and oocyte meiosisProgesterone activates a progesterone receptor membrane component 1-dependent mechanism that promotes human granulosa/luteal cell survival but not progesterone secretionProgesterone receptor signalling in retinal photoreceptor neuroprotection.Progesterone receptor membrane component 1/Sigma-2 receptor associates with MAP1LC3B and promotes autophagy.Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients.Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.Progesterone, Inflammatory Cytokine (TNF-α), and Oxidative Stress (H2O2) Regulate Progesterone Receptor Membrane Component 1 Expression in Fetal Membrane Cells.New insight on a possible mechanism of progestogens in terms of breast cancer risk.Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender DifferencesPGRMC1: a new biomarker for the estrogen receptor in breast cancer.Progesterone modulates endothelial progenitor cell (EPC) viability through the CXCL12/CXCR4/PI3K/Akt signalling pathway.Progesterone Receptor Membrane Component 1 suppresses the p53 and Wnt/β-catenin pathways to promote human pluripotent stem cell self-renewal.AG 205, a progesterone receptor membrane component 1 antagonist, ablates progesterone's ability to block oxidative stress-induced apoptosis of human granulosa/luteal cells†.CYB5D2 enhances HeLa cells survival of etoposide-induced cytotoxicity.PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma.Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.Pgrmc1 Knockout Impairs Oocyte Maturation in Zebrafish
P2860
Q27000111-9E15BA2B-CE01-410D-A695-9E5520844F00Q33749200-A0186796-92F3-48F9-A3ED-ABA83F9C8B0EQ33782364-C195E4C0-6020-475E-BDAB-D2CE0A3CD8F7Q33914314-8FA055D9-162C-48D7-B04F-CC9D202138CDQ33986752-2C1F132C-E56F-4024-87B6-9359AADA09B7Q34042708-3A40F3EE-CEA3-4F4C-999A-7A2425BB06D2Q34181972-78C2288E-8BBF-4BE2-A03E-077202317FBFQ34250906-05821453-0F52-473D-919D-507E0B0076B3Q34570541-01D908E0-74F3-4DAC-A436-8A942DA69855Q34587636-A6081929-8BA5-4BFE-9268-5188962CBB51Q34656815-673D9030-DE08-4AFD-9A3C-19C7D182EE5CQ35085921-77027B23-37BE-4BCB-AACA-877EB6BA8ECFQ35136665-E7F055B8-8D7D-48E6-A51A-4B94444EF066Q35617134-99D96361-3039-4045-A858-E3C1E20C52B3Q35922605-26BB16E1-C68D-401D-A398-A7CE77A59637Q36255955-281D70A5-E64D-4E90-8CC7-AE145BA259FBQ36430759-B3350E21-C43C-417C-B113-0153B41B7919Q36713044-8250ED81-8F1E-4C75-B41D-308E2144C499Q36844266-35354E7E-6810-4C15-A3A1-33F21AD5AFEFQ36966197-6A2D6771-CEAD-456C-B9C7-7B9086B5495DQ37138140-589B8A39-D5DA-481F-8B32-32DFDE88F258Q37143188-3C42B42D-5B4C-4E7C-993C-A637A3856024Q37257543-779ACEC6-C410-4F94-B2FC-4FD92C59FBD0Q38829565-0EE07370-C868-4A3D-861A-16D4085B8840Q39082987-3D7B3C71-0885-4A4E-8D80-B8CFC3F98FA6Q39473591-93B85DDF-DB85-4DCE-8D7F-B535DB2517BFQ39865023-7E0F066A-2195-463A-9B6C-1A139DE638A6Q39965267-60EBD5F9-C657-4C25-AB2A-12629441026CQ40953525-5FB48045-96BC-472A-97AE-9531C2792345Q42343539-F334D486-5880-41CB-93BE-6191E78DBA26Q43161284-FD9048EE-79FE-4A9A-850C-7886C891F994Q48946164-8C7E4322-CE83-475C-8943-5DFB70BF883CQ50303613-A322D818-9F24-409F-97CC-D9BA955BFA41Q51074165-0F2D7F45-E0D0-4955-B98F-E949C1516D81Q53243201-AC2AB566-5580-4A67-8451-B8FE83389E0DQ53641821-8B1600D2-97D7-4D53-A046-FBB43B64FA52Q54251377-51E6D832-FFAF-4E5C-B891-1885486931BBQ57492366-226160B7-8EA9-4385-B8CC-7949DA3FEE09
P2860
Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Regulation of ovarian cancer c ...... receptor membrane component-1.
@ast
Regulation of ovarian cancer c ...... receptor membrane component-1.
@en
Regulation of ovarian cancer c ...... receptor membrane component-1.
@nl
type
label
Regulation of ovarian cancer c ...... receptor membrane component-1.
@ast
Regulation of ovarian cancer c ...... receptor membrane component-1.
@en
Regulation of ovarian cancer c ...... receptor membrane component-1.
@nl
prefLabel
Regulation of ovarian cancer c ...... receptor membrane component-1.
@ast
Regulation of ovarian cancer c ...... receptor membrane component-1.
@en
Regulation of ovarian cancer c ...... receptor membrane component-1.
@nl
P2093
P356
P1476
Regulation of ovarian cancer c ...... receptor membrane component-1.
@en
P2093
John J Peluso
Kathryn Phoenix
Kevin P Claffey
M Melinda Saunders
Xiufang Liu
P304
P356
10.1210/JC.2007-2771
P407
P577
2008-03-04T00:00:00Z